ARC and MNR Archive
Audiences can view digital video, listen to soundbites, view and download photos, download documents, and share what they find with friends and colleagues with the click of a button.
MNRs
Health & Pharma New study suggests more than 8 percent of children with cancer have genetic predisposition  Perceptions of Counterfeit Medicines: Only 12% of Americans Feel They Have Enough Information  Novartis receives FDA regular approval for Tafinlar® + Mekinist® to treat aggressive form of melanoma based on long-term survival data  EUROPEAN COMMISSION APPROVES KYPROLIS® (CARFILZOMIB) FOR COMBINATION USE IN THE TREATMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA  St. Baldrick’s Foundation Changes the Narrative for Kids with Cancer  DARZALEX® (DARATUMUMAB) APPROVED BY U.S. FDA: FIRST HUMAN ANTI-CD38 MONOCLONAL ANTIBODY AVAILABLE FOR THE TREATMENT OF MULTIPLE MYELOMA  TAGRISSO™ (OSIMERTINIB) (AZD9291) APPROVED BY THE US FDA AS TREATMENT FOR PATIENTS WITH EGFR T790M MUTATION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER  Colgate Total® Teams Up with the American Diabetes Association®and Funnyman Joey Fatone to Bring “30 Days of Laughter” to the Diabetes Community  National Survey Reveals Patients with Potentially Deadly Interstitial Lung Diseases are Enduring Significant Diagnosis Delays and Errors  Second World Pancreatic Cancer Day to Elevate Conversations, Awareness and Education About One of the Deadliest Cancers  Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis  New Survey of U.S. Adults with Diabetes Reveals Less than Half Understand Their Risk for Vision Loss  Autism Speaks and Ad Council Launch New PSAs with 3D and Stop-Motion Animation Inspired by the Story of a Child with Autism  MARCH OF DIMES PREMATURE BIRTH REPORT CARD GRADES CITIES, COUNTIES; FOCUSES ON RACIAL AND ETHNIC DISPARITIES  Grammy Award-winning Singer Patti LaBelle Teams Up with American Lung Association’s LUNG FORCE to Educate the Public about Lung Cancer  ALLERGAN OUTLINES OPEN SCIENCE MODEL AND HIGHLIGHTS KEY DEVELOPMENT PROGRAMS AT R&D DAY  Calling all mothers to participate in ONE DROP’s online fundraising campaign.  Chiasma Supports Acromegaly Awareness with Launch of New Online Resource for Patients and Caregivers  Researchers Find Hookah Smoking Can Lead to Serious Oral Conditions  New Heartwarming Campaign Aims to Save Lives of People with Oft-Misdiagnosed Deadly Disease  Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery  Merck and the National Sleep Foundation Urge Insomnia Sufferers to Prioritize Sleep and MoveBeyond Tired  FDA APPROVES IMLYGIC™ (TALIMOGENE LAHERPAREPVEC) AS FIRST ONCOLYTIC VIRAL THERAPY IN THE US  U.S. FDA APPROVES BELBUCA™(BUPRENORPHINE) BUCCAL FILM FOR CHRONIC PAIN MANAGEMENT  Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX™ - First Low Dose SoluMatrix®Meloxicam for Osteoarthritis Pain  VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study  Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire Young People to Donate Blood  Merrimack Announces U.S. FDA Approval of ONIVYDE™ (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer  AMGEN FOUNDATION ANNOUNCES NEW $4 MILLION COMMITMENT TO BRING HANDS-ON BIOTECHNOLOGY LABS TO SECONDARY SCHOOL STUDENTS  23andMe Launches New Customer Experience - Reports Include Carrier Status That Meet FDA Standards, Wellness, Traits, and Ancestry  Metastatic Breast Cancer Alliance Launches New Public Awareness Campaign Focusing on Lack of Understanding of Metastatic Breast Cancer  Philips Sonicare teams up with its toughest critic yet - kids - to put its newest power toothbrush and connected app to the test  BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR SYNERGY™ BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM  INVUITY® LAUNCHES HIDDEN SCAR™PROGRAM FOR BREAST CANCER SURGERY AT AMERICAN COLLEGE OF SURGEONS (ACS) ANNUAL CLINICAL CONGRESS 2015  Sanofi Announces Launch of Authorized Generic Version of Arava® (Leflunomide) Tablets  The Leukemia & Lymphoma Society Commits $28.6 Million to New Cancer Research Funding  CYCLE FOR SURVIVAL LAUNCHES 2016 EVENT REGISTRATION WITH A SEA OF STATIONARY BIKES IN TIMES SQUARE  Gout and Elevated Uric Acid Are Linked to Several Serious Health Risks - Yet Few Americans Understand the Connection  American Heart Association launches new national initiative with goals to target growing impact of heart failure  BOSTON SCIENTIFIC LAUNCHES THE CAPTIVATOR™ EMR DEVICE TO TREAT DISEASES OF THE UPPER GI TRACT  ELUVIA™ DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATES 12-MONTH PRIMARY PATENCY OF 96.1 PERCENT  TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score®are free of breast cancer recurrence after five years of hormone therapy alone  Supergoop! Co-Owner Maria Sharapova and Founder & CEO Holly Thaggard Announce the Launch of Project Black Dot  Mead Johnson Helps Advance the Nutritional Care for Preterm Infants  Danica Patrick All Smiles as Aspen Dental Management, Inc. Extends Partnership, Doubles Commitment  Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial  West Pharmaceutical Services, Inc. And HealthPrize Technologies Announce Self-Reporting And Barcoding Capabilities For Self-Injection Technology  American Association for Cancer Research National Survey Shows 74 Percent of Voters Want More Federal Funding for Cancer Research  New Myths and Truths About Thyroid Cancer Education Initiative Aims to Shine a Light on the Truths about Thyroid Cancer  New 5-Year Results of a Landmark Study Confirm LINX Procedure as a Beneficial Treatment for Gastro-esophageal Reflux Disease  AbbVie’s HUMIRA® (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa  Urology Care Foundation and NFL Kick-Off Another Great Season for Prostate Cancer Awareness  BAYER PLEDGES 1 MILLION HANDS-ON SCIENCE LEARNING EXPERIENCES FOR CHILDREN BY 2020 TO HELP INSPIRE NEXT GENERATION OF INNOVATORS  Researchers and Advocates Recognized for Their Contributions in the Fight Against Cancer  Most Americans Don’t Know an Important Health Number that Could Be Putting Them at Risk for Gout  US FDA APPROVES EXPANDED INDICATION FOR BRILINTA TO INCLUDE LONG-TERM USE IN PATIENTS WITH A HISTORY OF HEART ATTACK  Brian Custer Teams Up with the Prostate Cancer Foundation to Urge Men to “Man Up and Get Checked”  Invest in a Child’s Future: St. Baldrick’s Foundation Calls for Increased Focus on Funding Pediatric Cancers  Duchesnay USA Publishes Corrective Messaging through Kim Kardashian’s Social Media Accounts in Response to FDA’s Request  PROOF OF IMPACT: THE LEUKEMIA & LYMPHOMA SOCIETY IS MAKING PROGRESS TOWARD A WORLD WITHOUT BLOOD CANCERS  FDA APPROVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA™ (EVOLOCUMAB)  September is Childhood Cancer Awareness Month St. Jude Children's Research Hospital® encourages communities to join the fight  HEART RHYTHM SOCIETY RAISES AWARENESS OF THE DEVASTATING IMPACT OF AFIB-RELATED STROKE FOR MILLIONS OF AMERICANS  SPROUT PHARMACEUTICALS RECEIVES FDA APPROVAL OF ADDYI™ (FLIBANSERIN 100 MG)  FDA expands use of Novartis drug Promacta® to include treatment of children ages 1 and older with chronic immune thrombocytopenia  U.S. DEPARTMENT OF JUSTICE TO ARRAIGN SENIOR PHARMACYCHECKER.COM EXECUTIVE FOR CHARGES RELATED TO SELLING $78 MILLION WORTH OF MISLABELED AND COUNTERFEIT DRUGS  Novavax Announces Positive Top-Line Data from Phase 2 RSV F-Protein Vaccine Clinical Trial in Older Adults  Social media campaign to rally supporters around the world in tackling the second most common cancer among men  Crohn’s & Colitis Foundation of America Launches Indoor Cycling Event – spin4 crohn’s & colitis cures  FDA APPROVES THE RESHAPE™ INTEGRATED DUAL BALLOON SYSTEM, A FIRST-OF-ITS-KIND NON-SURGICAL WEIGHT LOSS PROCEDURE FOR PEOPLE WITH MILD TO MODERATE OBESITY  Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients  FDA APPROVES KYPROLIS® (CARFILZOMIB) FOR COMBINATION USE IN THE TREATMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA  Abbott’s iDesign System Creates 3-D Map of the Eye for Precise, Personalized LASIK Vision Treatment  EUROPEAN COMMISSION APPROVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA™  Duchesnay USA encourages pregnant women to speak with their healthcare professional about the only FDA-approved prescription treatment for morning sickness  Novartis’ new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril/valsartan)  PERICOACH®, NEW FDA-APPROVED PELVIC FLOOR TRAINING SYSTEM FOR WOMEN, NOW AVAILABLE  Eyeglass World Launches First Retail Collection of Prescription Lenses for Smart Glass Devices  Biogen and SELF Help Women Reimagine Daily Life with Relapsing Multiple Sclerosis (RMS)  “Strike Through Cancer” Campaign Benefitting MD Anderson Cancer Center Also Features In-Store Tributes to Loved Ones Affected by the Disease  Prostate Cancer Foundation Steps Into the Ring to Knock Out Prostate Cancer for Good  Merck Launches New Program That Encourages Women to “Rule the Real Talk” and Prioritize Their Sexual Health  Novartis gains FDA approval for Promacta® providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder  Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment  Shriners Hospitals for Children and NASCAR Driver David Ragan Join Forces to Reduce the Risks of Childhood Injuries |
The message is clear Multimedia public relations is not just the wave of the future. It’s the reality of today. |
